Mark J. Siedner

Sep 18, 2024 | statnews.com | Mark J. Siedner |Rochelle P. Walensky

At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug in HIV prevention brought a raucous standing ovation. Lenacapavir, a novel drug given as an injection under the skin every six months, was 100% successful in preventing HIV in adolescent girls and young women in two countries in Africa. It felt to many like a generational moment.

Sep 22, 2023 | journals.plos.org | Seth C Inzaule |Amsterdam UMC |Mark J. Siedner |Susan J Little

Loading metrics Open Access Policy Forum Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies. See all article types » Citation: Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, et al. (2023) Recommendations on data sharing in HIV drug resistance research. PLoS Med 20(9): e1004293.